Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD

Thrombosis Research

Volumn 126, Issue 3, 2010, Pages 227-231

  Castaman, G ^a   Tosetto, A ^a   Cappelletti, A ^a   Goodeve, A ^b   Federici, A B ^c   Batlle, J ^d   Meyer, D ^e   Goudemand, J ^f   Eikenboom, J C J ^g   Schneppenheim, R ^h   Budde, U ⁱ   Ingerslev, J ^j   Lethagen, S ^k   Hill, F ^l   Peake, I R ^b   Rodeghiero, F ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF MILAN   (Italy)

^d Hospital Teresa Herrera   (Spain)

^e INSERM   (France)

^f UNIV LILLE   (France)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ Aesculabor   (Germany)

^j AARHUS UNIVERSITY HOSPITAL   (Denmark)

^k LUND UNIVERSITY   (Sweden)

^l BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

more..

Author keywords

Inherited bleeding disorders; von Willebrand disease; von Willebrand factor

Indexed keywords

ANTIGEN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOMATION, LABORATORY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPE; HUMANS; LATEX FIXATION TESTS; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; ROBOTICS; ROC CURVE; SENSITIVITY AND SPECIFICITY; VON WILLEBRAND DISEASE, TYPE 1; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 77956265936     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.06.013     Document Type: Article

References (19)

1. F. Rodeghiero, G. Castaman, and E. Dini Epidemiological investigation of the prevalence of von Willebrand's disease Blood 69 1987 454 459
2. F. Rodeghiero, G. Castaman, and A. Tosetto von Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease: results based on an epidemiological investigation Thromb Haemost 64 1990 349 352
3. J.E. Sadler, P.M. Mannucci, E. Berntorp, N. Bochkov, V. Boulyjenkov, and D. Ginsburg Impact, diagnosis and treatment of von Willebrand disease Thromb Haemost 84 2000 160 174
4. G. Castaman, J.C.J. Eikenboom, R. Bertina, and F. Rodeghiero Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiologic investigation Thromb Haemostas 82 1999 1065 1070
5. J.E. Sadler, U. Budde, J.C. Eikenboom, E.J. Favaloro, F.G. Hill, and L. Holmberg Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor J Thromb Haemost 4 2006 2103 2114
6. G. Castaman, S. Lethagen, A.B. Federici, A. Tosetto, A. Goodeve, and U. Budde Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD Blood 111 2008 3531 3539
7. F. Rodeghiero, G. Castaman, and A. Tosetto How I treat von Willebrand disease Blood 114 2009 1158 1165
8. E.J. Favaloro, J. Smith, P. Petinos, M. Hertzberg, J. Koutts, and on behalf of the RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel Laboratory testing for von Willebrand's Disease: An Assessment of Current Diagnostic Practice and Efficacy by Means of a Multi-laboratory Survey Thromb Haemost 82 1999 1276 1282
9. G. Castaman, A. Tosetto, and F. Rodeghiero Von Willebrand disease N. Key, M. Ma kris, O'Shaughnessy D. Lillicrap, Practical Hemostasis and Thrombosis 2nd edition 2009 Wiley-Blackwell Oxford 73 87
10. J. Cejka Enzyme immunoassay for factor VIII-related antigen CIin Chem 28 1982 1356 1358
11. K. Sukhu, P.G. Martin, L. Cross, D.M. Keeling, and P.L. Giangrande Evaluation of the von Willebrand factor antigen (vWF-Ag) assay using an immuno-turbidimetric method (STA Liatest vWF) automated on the MDA 180 coagulometer Clin Lab Haematol 22 2000 29 32
12. A. Veyradier, E. Fressinaud, M. Sigaud, M. Wolf, and D. Meyer A new automated method for von Willebrand factor antigen measurement using latex particles Thromb Haemost 81 1999 320 321
13. J.L. Pittet, V. Barbalat, M. Sanvert, C. Villard, S. Jorieux, and C. Mazurier Evaluation of a new automated ELISA test for von Willebrand factor using two monoclonal antibodies Blood Coagul Fibrinol 8 1997 209 215
14. P. Villa, J. Iborra, J. Serra, A. Gilsanz, P. Casana, and J.A. Aznar Evaluation of an automated method for the quantification of von Willebrand factor antigen. Its application in the study of vascular dysfunction Haematologica 86 2001 1180 1185
15. A. Goodeve, J. Eikenboom, G. Castaman, F. Rodeghiero, A.B. Federici, and J. Batlle Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD) Blood 109 2007 112 121
16. D.G. Altman, and J.M. Bland Measurement in medicine: the analysis of method comparison studies Statistician 32 1983 307 317
17. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36
18. A. Tosetto, G. Castaman, and F. Rodeghiero Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach Blood 15 111 2008 3998 4003
19. F. Rodeghiero, G. Castaman, and A. Tosetto Optimizing treatment of von Willebrand disease by using phenotypic and molecular data Hematology Am Soc Hematol Educ Program 2009 113 123